Neuroprotection in Schizophrenia and Its Therapeutic Implications
Yong-Ku Kim, Kyoung-Sae Na
Psychiatry Investig. 2017;14(4):383-391.   Published online 2017 Jul 11     DOI:
Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
PatrĂ­cia C. Pires, Adriana O. Santos
Journal of Controlled Release.2018; 270: 89.     CrossRef
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Stefano Aringhieri, Marco Carli, Shivakumar Kolachalam, Valeria Verdesca, Enrico Cini, Mario Rossi, Peter J. McCormick, Giovanni U. Corsini, Roberto Maggio, Marco Scarselli
Pharmacology & Therapeutics.2018; 192: 20.     CrossRef